secwatch.observer — SEC 8-K summary
======================================

Issuer:     Aspire Biopharma Holdings, Inc. (ASBP)
CIK:        0001847345
Form:       8-K
Filed at:   2025-06-10T23:59:59+00:00
Accession:  0001641172-25-014445
Event type: leadership
Sentiment:  neutral
Materiality: 0.75
Item codes: 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud

Aspire Biopharma CEO Kraig Higginson Steps Down, Michael C. Howe Appointed as New CEO
--------------------------------------------------------------------------------

- Kraig Higginson resigned as CEO effective June 10, 2025, and will serve as Executive Chairman.
- Board appointed Michael C. Howe, previously an independent board member, as CEO effective June 10, 2025.
- Howe led MinuteClinic from 19 clinics to sale to CVS in 2006, delivering nearly sixfold return for investors.
- Howe has 40+ years experience at Procter & Gamble, PepsiCo, Arby's (CEO), and early-stage healthcare companies.
- Press release issued June 10, 2025, detailing leadership transition and Howe's background.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1847345/000164117225014445/0001641172-25-014445-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1847345/000164117225014445/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001641172-25-014445

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer